20
Cambrex Profarmaco Milano Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.
One of their notable products is CLONAZEPAM, with a corresponding US DMF Number 11351.
Remarkably, this DMF maintains an Active status since its submission on February 17, 1995, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 06, 2014, and payment made on August 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II